Actively Recruiting
Study of the MyHeartSentinel Device Monitoring Heart Signals During Heart Failure Episodes in Hospital and After Discharge
Led by University Hospital, Caen · Updated on 2026-06-26
70
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What this Trial Is About
Chronic heart failure is a widespread health issue affecting millions globally and causing significant mortality and hospital admissions. This study explores the use of the MyHeartSentinel MHS system, a skin-based device that monitors heart electrical and mechanical signals in patients with chronic heart failure. The goal is to create a database linking these signals with clinical and biological changes to aid early detection of worsening heart failure. The study involves 70 patients with chronic heart failure, including those hospitalized for heart failure worsening or for hemodynamic assessment. The MyHeartSentinel device collects cardiac signals, which researchers will analyze alongside biological and clinical data. This information will help develop an algorithm for detecting heart failure decompensation risk. Participants will wear the MHS device, allowing continuous cardiac monitoring. Researchers will assess changes in ECG and other cardiac signals related to heart failure status. Data collected will include biological markers and clinical evaluations. The primary outcome is detecting ECG modifications at baseline. The study spans from July 2025 to March 2028, focusing on building a monitoring solution for better management of heart failure.
CONDITIONS
Brief Title
EXPLORATORY STUDY OF THE MYHEARTSENTINEL SYSTEM, A CARDIAMETRICS MEDICAL DEVICE
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
